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Abstract
Background: Mesenchymal stem cells (MSCs) are the most promising cell types for bone regeneration and repair
due to their osteogenic potential. MSC differentiation is precisely regulated and orchestrated by the mechanical
and molecular signals from the extracellular environment, involving complex pathways regulated at both the
transcriptional and post-transcriptional levels. However, the potential role of long noncoding RNA (lncRNA) in the
osteogenic differentiation of human MSCs remains largely unclear.
Methods: Here, we undertook the survey of differential coding and noncoding transcript expression profiling and
functional network analysis during osteogenic differentiation of human bone marrow mesenchymal stem cells
(BMSCs) using human whole transcriptome microarray. The key pathways, mRNAs, and lncRNAs controlling
osteogenic differentiation of BMSCs were identified by further bioinformatic analysis. The role of lncRNA in the
osteogenic differentiation of MSCs was verified by lncRNA overexpression or knockdown methods.
Results: A total of 1269 coding transcripts with 648 genes significantly upregulated and 621 genes downregulated,
and 1408 lncRNAs with 785 lncRNAs significantly upregulated and 623 lncRNAs downregulated were detected along
with osteogenic differentiation. Bioinformatic analysis identified that several pathways may be associated with
osteogenic differentiation potentials of BMSCs, such as the MAPK signaling pathway, the Jak-STAT signaling pathway,
the Toll-like receptor signaling pathway, and the TGF-beta signaling pathway, etc. Bioinformatic analysis also revealed
13 core regulatory genes including seven mRNAs (GPX3, TLR2, BDKRB1, FBXO5, BRCA1, MAP3K8, and SCARB1), and six
lncRNAs (XR_111050, NR_024031, FR374455, FR401275, FR406817, and FR148647). Based on the analysis, we identified
one lncRNA, XR_111050, that could enhance the osteogenic differentiation potentials of MSCs.
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Conclusions: The potential regulatory mechanisms were identified using bioinformatic analyses. We further predicted
the interactions of differentially expressed coding and noncoding genes, and identified core regulatory factors by co-
expression networks during osteogenic differentiation of BMSCs. Our results could lead to a better understanding of
the molecular mechanisms of genes and lncRNAs, and their cooperation underlying MSC osteogenic differentiation
and bone formation. We identified that one lncRNA, XR_111050, could be a potential target for bone tissue
engineering.
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Background
Mesenchymal stem cells (MSCs) are the most promising
cell types for bone regeneration and repair due to their
osteogenic potential [1, 2]. Bone marrow mesenchymal
stem cells (BMSCs) are considered the gold standard for
use in bone tissue regeneration among MSCs, and they
are an important source of multipotent progenitor cells
with self-renewal capacity that can differentiate into
osteoblasts, chondrocytes, and adipocytes with great
potential for clinic applications [1, 3]. BMSC differenti-
ation is precisely regulated and orchestrated by the
mechanical and molecular signals from the extracellular
environment, involving complex pathways regulated at both
the transcriptional and post-transcriptional levels [4–6].
Long noncoding RNAs (lncRNAs) are a class of nonpro-
tein coding genes. Recent advances in high-throughput
technology and computational methods allow for an
unprecedented analysis of such transcripts. Tens of thou-
sands of lncRNAs transcribed from mammalian genomes
have been identified [7–12]. Recent studies have shown
the regulatory role and functional diversity of lncRNAs.
Many functional lncRNAs show tissue-specific expression
patterns and distinct subcellular localizations [9, 11, 13, 14].
Growing evidence suggests that lncRNAs are important
modulators of gene expression via their interaction with
DNA, RNA, or protein [15–25], while determining the
function of individual lncRNAs remains a challenge. Some
lncRNAs have been shown to regulate osteogenic differenti-
ation of MSCs [26–31]. However, the particular functions
of lncRNAs during osteogenic differentiation of human
BMSCs still remain largely unclear.
A previous study found that osteogenic differentiation
markers were enhanced and that the stemness marker
NANOG was downregulated at day 7 of osteogenic
differentiation induction in BMSCs, indicated that day 7
of the induction was the transit point of the onset of
osteogenic differentiation in BMSCs [32]. In the present
study, we aimed to investigate the key mRNAs and
lncRNAs for the transit point of osteogenic differenti-
ation in MSCs. Here, we performed microarray analysis
to identify the differential coding and long noncoding
transcript expression profiling between noninduced and
day 7 osteogenic-differentiated human BMSCs. A total
of 1269 coding transcripts and 1408 lncRNAs were
identified with differential expression during osteo-
genic differentiation in BMSCs. We further predicted
interactions between coding and noncoding genes,
and identified core regulatory factors by bioinfor-
matic analysis. Our results also highlight the signifi-
cant involvement of one lncRNA, XR_111050, in the
positive regulation of osteogenic differentiation of
BMSCs.
Results
The profiling of differentially expressed mRNAs and
lncRNAs during osteogenic differentiation of BMSCs
To identify the differentially expressed lncRNAs and
mRNAs during osteogenic differentiation of MSCs, we
first applied the RVM t test to filter the genes that were
differentially expressed, and then the differentially
expressed genes with 1.5-fold changes were selected ac-
cording to the p value threshold false discovery rate
(FDR) for subsequent analysis. A total of 1269 coding
transcripts with differential expression were identified
during osteogenic differentiation (p < 0.05, FDR < 0.05);
of these, 648 were upregulated and 621 were downregu-
lated in BMSCs at 7 days after osteogenic induction
compared to the uninduced BMSCs (Additional file 1:
Table S1). In addition, a total of 1408 lncRNAs were
differentially expressed after osteogenic differentiation
(p < 0.05, FDR < 0.05); of these, 785 were upregulated
and 623 were downregulated in BMSCs at 7 days
after osteogenic induction compared to the uninduced
BMSCs (Additional file 2: Table S2).
To confirm the reliability of the microarray data,
we randomly selected six differentially expressed
mRNAs (FGF7, FOXO1, STAT2, TMEM156, FOXM1,
and FOXC2), and nine differentially expressed lncRNAs
(XR_111050, NR_003255, NR_027621, NR_002196,
NR_045555, NR_024593, NR_034115, NR_034181, and
NR_037595) to analyze their expression with real-time
polymerase chain reaction (RT-PCR). The RT-PCR results
confirmed that the expression levels of these randomly
selected 15 genes were consistent with the microarray
results (Table 1).
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Bioinformatic analysis of microarray data during
osteogenic differentiation of BMSCs
To identify the key factors that controlled osteogenic
differentiation of BMSCs, we performed gene ontology
(GO) analysis and pathway analysis. First, GO analysis
was performed to enrich the significant functions from
the differentially expressed genes obtained during osteo-
genic differentiation of BMSCs. We obtained 171 GO func-
tions according to p value and FDR (p < 0.05, FDR < 0.05)
including 99 upregulated GO functions and 72 downregu-
lated GO functions (Additional file 3: Table S3). The nega-
tive logarithm of the p value (–LgP) was used to represent
the correlation between gene expression and the relevant
biological process. Some important upregulated GO func-
tions may be related to osteogenic differentiation, including
response to stimulus, DNA-dependent transcription, ion
transport, cell adhesion, and skeletal system development,
and some important downregulated GO functions that
were related to osteogenic differentiation were cell cycle,
cell division, mitosis, DNA replication, and DNA-
dependent transcription (Fig. 1a; Additional file 3:
Table S3). We obtained 331 significantly upregulated
genes and 297 significantly downregulated genes from
enriched GO functions (p <0.01, FDR < 0.05).
We then enriched the significantly changed pathways
that mediated the functions of the differentially
expressed genes based on the KEGG database, and iden-
tified a total of 67 significant pathways related to differ-
ential gene expression which may play key roles during
osteogenic differentiation of BMSCs (p < 0.05); of these,
37 pathways involved upregulated genes and 30 path-
ways involved downregulated genes (Fig. 1b; Additional
file 4: Table S4). Some important pathways that may
related to osteogenic differentiation were enriched from
upregulated genes, including cytokine-cytokine receptor
interaction, extracellular matrix (ECM)-receptor inter-
action, the Toll-like receptor signaling pathway, and the
chemokine signaling pathway. Some important pathways
may be related to osteogenic differentiation enriched
from downregulated genes were cell cycle, DNA replica-
tion, pyrimidine metabolism, and purine metabolism
(Fig. 1b; Additional file 4: Table S4).
Among the significant pathways related to differential
genes, a total of 170 upregulated genes and 152 down-
regulated genes was identified according to the p value
(p < 0.05; Additional file 5: Table S5). The Path-Net was
the interaction net of the significant pathways of the
differential expression genes, and was built according to
the interaction among pathways of the KEGG database
to find the interaction between the significant pathways
directly and systemically. After performing Path-net ana-
lysis to generate an interaction network of these signifi-
cantly changed pathways, we could identify the
relationship between the pathways enriched from differ-
ential expression genes and identify why a certain path-
way was activated (Fig. 2). Our results identified the
crosstalk of key pathways which may have an important
role in the differentiation regulation of BMSCs. The
crosstalk among the MAPK signaling pathway, the Jak-
STAT signaling pathway, the Toll-like receptor signaling
Table 1 The real-time polymerase chain reaction (RT-PCR) results showed differential mRNA and lncRNA expression levels during
osteogenic differentiation of bone marrow mesenchymal stem cells
RT-PCR results Microarray results
Gene symbol 0 days 7 days 7-day/0-day (fold-change) Regulation
XR_111050 1.00 ± 0.063 32.76 ± 4.29** 14.13 Up
NR_045555 1.00 ± 0.11 4.08 ± 0.28** 5.14 Up
NR_002196 1.00 ± 0.089 10.08 ± 1.53** 4.7 Up
NR_024593 1.00 ± 0.24 2.16 ± 0.29** 4.23 Up
NR_003255 1.00 ± 0.11 3.78 ± 0.27** 2.68 Up
NR_027621 1.00 ± 0.081 2.86 ± 0.18** 1.88 Up
NR_034115 1.00 ± 0.19 0.20 ± 0.051** 0.27 Down
NR_037595 1.00 ± 0.27 0.57 ± 0.062** 0.32 Down
NR_034181 1.00 ± 0.085 0.39 ± 0.072** 0.49 Down
FGF7 1.00 ± 0.10 14.42 ± 1.27** 17.86 Up
FOXO1 1.00 ± 0.14 4.33 ± 0.46** 3.97 Up
STAT2 1.00 ± 0.19 2.61 ± 0.42** 2.8 Up
TMEM156 1.00 ± 0.12 0.25 ± 0.059** 0.084 Down
FOXM1 1.00 ± 0.21 0.17 ± 0.031** 0.27 Down
FOXC2 1.00 ± 0.19 0.59 ± 0.082** 0.41 Down
GAPDH was used as an internal control. The results represent mean ± standard deviation from three independent experiments (mean value of gene expression/
GAPDH at day 0 was set as 1). Student’s t test was performed to determine statistical significance; **p < 0.01
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pathway, and the transforming growth factor (TGF)-beta
signaling pathway were identified to a high degree (Fig. 2;
Additional file 6: Table S6). We observed a high degree of
increased activity of apoptosis, the cytokine-cytokine
receptor interaction, the TGF-beta signaling pathway, the
Jak-STAT signaling pathway, and the Toll-like receptor
signaling pathway in a cluster of upregulating genes, and a
decreased activity of the MAPK signaling pathway, the cell
cycle, and the p53 signaling pathway in a cluster of down-
regulating genes (Fig. 2; Additional file 6: Table S6).
We constructed an interactions repository by a Signal-
net analysis (Signal-net) based on the significantly regu-
lated GOs and pathways to identify 92 core genes during
osteogenic differentiation of BMSCs according to the
degree of gene interaction (betweenness centrality)
(Fig. 3; Additional file 7: Table S7).
To obtain core mRNAs and lncRNA genes during
osteogenic differentiation of MSCs, we calculated the
Pearson correlation for each pair of genes and used the
most significantly correlated pairs to construct a coding-
noncoding gene co-expression (CNC) network to iden-
tify the interactions and significance degree amongst the
differentially expressed lncRNAs and mRNAs according
to clustering coefficient and degree (Additional file 8:
Figure S1 and Additional file 9: Figure S2). The closely
correlated mRNAs and lncRNAs were identified. One
mRNA was correlated with one or more lncRNAs and
vice versa. We identified 13 core regulatory genes in-
cluding seven mRNAs (GPX3, TLR2, BDKRB1, FBXO5,
BRCA1, MAP3K8, and SCARB1) and six lncRNAs
(XR_111050, NR_024031, FR374455, FR401275, FR406
817, and FR148647) according to clustering coefficient
and degree value (Additional file 10: Table S8; clustering
coefficient ≥0.9 and degree >7).
The lncRNA XR_111050 enhanced the osteogenic
differentiation potentials of MSCs
In the CNC networks, among the six lncRNAs, XR_111050
showed the most significant clustering coefficient. The RT-
PCR results showed that the expression of XR_111050
Fig. 1 Significant gene ontology (GO) analyses and pathways of differentially expressed genes during osteogenic differentiation. a The significant
GO of differentially expressed genes during osteogenic differentiation. b The significant pathways of differentially expressed genes during
osteogenic differentiation. The y axis shows the GO or pathway category and the x axis shows the negative logarithm of the p value (–LgP). A
larger –LgP indicated a smaller p value for the difference. ECM extracellular matrix, TGF transforming growth factor
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increased along with osteogenic differentiation of BMSCs
(Fig. 4a). To evaluate the effect of XR_111050 on osteogen-
esis, we inserted the XR_111050 sequence into a lentiviral
vector, which was then transduced into BMSCs via lenti-
viral infection. Enhanced expression of XR_111050 was
verified with RT-PCR in BMSCs (Fig. 4b). Two weeks after
osteogenic induction, our results showed that XR_111050
overexpression enhanced osteogenic differentiation of
BMSCs as shown by Alizarin red staining and quantitative
calcium measurements compared with cells infected with
the empty vector (Fig. 4c and d). RT-PCR analysis of
XR_111050-overexpressing BMSCs showed stronger
expression of osteogenic markers (including COL1A2 at 0,
3, and 10 days, OCN and OPN at 0, 3, and 7 days, and BSP
at 7 and 14 days after osteogenic induction) compared with
the control group (Fig. 4e–h). We also examined expression
of the key transcription factors RUNX2 and OSX for regu-
lating osteogenic differentiation. RT-PCR results showed
that XR_111050-overexpressing BMSCs had a significantly
higher RUNX2 mRNA level compared with cells in-
fected with the empty vector (Fig. 4i). On the other
hand, OSX expression levels did not significantly
differ between groups (data not shown). We designed
and introduced a short-hairpin RNA (shRNA) to tar-
get XR_111050. After selection, the knockdown effi-
ciency (80%) was verified by RT-PCR (Fig. 5a). Two
weeks after osteogenic induction, Alizarin red staining
and quantitative calcium measurements revealed that
mineralization was markedly decreased after depletion
of XR_111050 in BMSCs (Fig. 5b and c).
We then detected the expression of BDKRB2,
MAP3K8, SCARB1, TLR2, FR000997, FR374455,
NR_002744, NR_027293, and NR_034115 in BMSCs
after overexpression of XR_111050 to investigate pos-
sible correlations. The RT-PCR results showed that over-
expression of XR_111050 upregulated the expression of
BDKRB2, MAP3K8, TLR2, and FR000997 (Fig. 6a–d),
and downregulated the expression of NR_002744 and
NR_034115 compared with control group (Fig. 6e and f),
but the expression of SCARB1, FR374455, and
NR_027293 were not changed (data not shown).
To confirm whether XR_111050 had similar func-
tions in other MSCs, we detected the XR_111050 ex-
pression in periodontal ligament stem cells (PDLSCs)
and the RT-PCR results showed that the expression of
XR_111050 increased along with osteogenic differenti-
ation of PDLSCs (Additional file 11: Figure S3A). Then
we overexpressed XR_111050 in PDLSCs via lentiviral
infection. Enhanced expression of XR_111050 was
verified with RT-PCR in PDLSCs (Additional file 11:
Figure S3B). Two weeks after osteogenic induction,
Alizarin red staining and quantitative calcium mea-
surements revealed that mineralization was markedly
increased after overexpression of XR_111050 in
PDLSCs (Additional file 11: Figure S3C,D).
Discussion
MSC differentiation is precisely regulated and orches-
trated by mechanical and molecular signals that have
increasingly attracted great attention in recent years
Fig. 2 The interaction network of significant pathways (Path-net). The role of each pathway in the network was measured by counting its
connections to upstream and downstream pathways. A pathway with a high degree implied that it played an important role in the signaling
network. Blue represents downregulated pathways, red represents upregulated pathways, and yellow represents up- and downregulated
pathways. The lines indicate interactions between pathways. ECM extracellular matrix, TGF transforming growth factor
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[4, 6, 33–38]. Therefore, understanding the molecular
mechanisms underlying MSC differentiation and modulat-
ing lineage commitment of MSCs is of importance for
therapeutic purposes [39].
Intensive studies have demonstrated that a number of
critical signaling pathways are involved in regulating the
lineage commitment of MSCs, including TGF-β/BMP
signaling, Wnt signaling, Hedgehogs, Notch, and FGFs
[4, 40–43]. A large range of biological processes have
been reported to be associated with lncRNAs, which are
correlated with various human diseases and life pro-
cesses. Emerging evidence is revealing that lncRNAs
regulate differentiation of stem cells [44]. Some lncRNAs
have been reported to be key regulators of osteogenic
differentiation of MSCs in recent studies [27–31, 45, 46].
However, the role of lncRNAs on the lineage commit-
ment of MSCs remains largely unknown.
Here, we organized these studies to outline the profiling
of mRNAs and lncRNAs during osteogenic differentiation
of BMSCs. By comparing the lncRNA and mRNA expres-
sions of differentiated and undifferentiated BMSCs, we
identified 1269 differentially expressed mRNAs and 1408
differentially expressed lncRNAs. Our results provided a
dynamic variation profiling in the expressions of lncRNAs
and mRNAs during osteogenic differentiation of BMSCs,
and implied that upregulated lncRNAs and mRNAs were
Fig. 3 The interaction network of differentially expressed genes (Signal-net). In the Signal-net, the genes are characterized by measuring
their “betweenness centrality”, the number of times a node is located in the shortest path between two other nodes. This measure
reflects the importance of a node in a network relative to another. The circles represent important functional genes (red: upregulated
genes; blue: downregulated genes); the circle size represents the degree of interaction (betweenness centrality), and lines indicate the
interactions
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predominant during osteogenic differentiation of BMSCs.
The differentially expressed mRNAs and lncRNAs ob-
tained were used as candidates to screen the key genes
controlling osteogenic differentiation of BMSCs by further
bioinformatic analysis.
We screened for the important pathways involved in
the differentiation mechanism of BMSCs. Among the
important pathways, the cytokine-cytokine receptor
interaction pathway was demonstrated to be the domin-
ant pathway and 28 genes were enriched. Of these,
Fig. 4 XR_111050 enhanced the osteogenic differentiation of BMSCs. The BMSCs were transduced with XR_111050 lentiviral vector or with empty
vector. a XR_111050 expression increased during osteogenic differentiation as evaluated by qRT-PCR. b The enhanced XR_111050 expression in
BMSCs was verified with qRT-PCR. The increased XR_111050 expression enhanced mineralization of BMSCs as shown by c Alizarin red staining
and d calcium quantitative analysis. qRT-PCR results showed that enhanced XR_111050 expression resulted in upregulated expressions of COL1A2 (e),
OCN (f), BSP (g) and OPN (h) after osteogenic induction. i The enhanced XR_111050 expression increased RUNX2 expression in BMSCs. GAPDH was
used as an internal control. Student’s t test was performed to determine statistical significance. Error bars represent SD (n = 3). *p < 0.05, **p < 0.01. BSP
bone sialoprotein, COL1A2 collagen a-2(I) chain, d days, GADPH glyceraldehyde-3-phosphate dehydrogenase, OPN osteopontin, RUNX2 runt-related
transcription factor 2, W weeks
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TNFSF10 was identified as being significantly upregu-
lated, which functions as a negative regulator of bone
resorption by activating TNFRSF11B. The interaction or
correlation of these pathways were built with Path-Net
(the interaction net of the significant pathways of the
differential expression genes) according to the inter-
action amongst pathways of the KEGG database to find
the interaction among the significant pathways directly
and systemically. A pathway with a high degree implied
that it played an important role in the signaling network.
The Path-net analysis results indicated that the MAPK
signaling pathway, the Jak-STAT signaling pathway, the
Toll-like receptor signaling pathway, and the TGF-beta
signaling pathway may have important roles in the
differentiation regulation of BMSCs to a high degree. The
results are consistent with previous reports [4, 41, 47–50].
The Path-net identified in our results also provided in-
sights into the role of crosstalk among key signaling path-
ways regulating osteogenic differentiation of BMSCs.
Integration of signaling into signaling networks through
cross-talk with other signal transduction pathways con-
tributes to induction of specific activation and differenti-
ation pathways [51]. We identified that the Toll-like
receptor signaling pathway was involved in osteogenic
differentiation of BMSCs by targeting apoptosis, cytokine-
cytokine receptor interaction, the Jak-STAT signaling
pathway, and the MAPK signaling pathway. Recent
studies implied that signal transduction crosstalk is
Fig. 5 XR_111050 knockdown inhibited osteogenic differentiation of BMSCs. The BMSCs was transduced with short-hairpin RNAs (shRNA) to
silence XR_111050 (XR_111050sh) or with control shRNA (Contsh). a The reduced XR_111050 expression by shRNA was evaluated by qRT- PCR.
XR_111050 knockdown inhibited mineralization, as shown by results of Alizarin red staining (b) and calcium quantitative analysis (c). Error bars
represent SD (n = 3). **p < 0.01. GADPH glyceraldehyde-3-phosphate dehydrogenase
Fig. 6 XR_111050 regulated the expression of BDKRB2, MAP3K8, TLR2, FR000997, NR_002744, and NR_034115 in BMSCs. qRT-PCR results showed
that enhanced XR_111050 expression resulted in upregulated expression of BDKRB2 (a), MAP3K8 (b), TLR2 (c), and FR000997 (d), and downregulated
expression of NR_034115 (e) and NR_002744 (f). GAPDH was used as an internal control. Student’s t test was performed to determine statistical
significance. Error bars represent SD (n = 3). *p < 0.05, **p < 0.01. GADPH glyceraldehyde-3-phosphate dehydrogenase
Zhang et al. Stem Cell Research & Therapy  (2017) 8:30 Page 8 of 13
regulated in a dynamic manner, and that dysregulation of
signal transduction crosstalk may contribute to pathogen-
esis [52]. For example, our results showed that signifi-
cantly upregulated IL6 was associated with multiple
signaling pathways, including the cytokine-cytokine recep-
tor interaction, the Toll-like receptor signaling pathway,
and the Jak-STAT signaling pathway, which can enhance
osteogenic differentiation [4, 53].
We then predicted some core regulating factors using
bioinformatic analysis of differentially expressed mRNAs
and lncRNAs. We constructed a potential interaction
between mRNAs and lncRNAs by CNC network, and
identified key genes, such as GPX3, TLR2, BDKRB1,
MAP3K8, and SCARB1, and lncRNAs, such as
XR_111050 and NR_024031. TLR2 and MAP3K8, as
component of the Toll-like receptor and MAPK signal-
ing pathways which is upregulated during osteogenic
differentiation of BMSCs in this study, may participate
in osteogenic differentiation via positive or negative
regulation of lncRNAs. Studies have suggested that the
osteogenic differentiation seems to be enhanced by
TLR2 activation in human BMSCs [50, 54, 55], which
may work through NF-κB activation [55, 56], while
MAP3K8 is an important mediator of intracellular
mechanotransduction in human MSCs which is related
to shear stress that can induce osteogenic differentiation
of human MSCs [57, 58]. These data may provide clues
to the potential role of interaction between lncRNAs
and TLR signaling or MAPK signaling on osteogenic
differentiation of BMSCs. GPX3, BDKRB1, and SCARB1
are involved in bone formation and absorption [59–61].
GPX3 belongs to the glutathione peroxidase family,
which catalyzes the reduction of organic hydroperoxides
and hydrogen peroxide by glutathione, and thereby pro-
tect cells against oxidative damage [62]. A previous in-
vestigation discovered that elderly osteoporotic women
with hip fractures had increased expression of GPX3,
suggesting increased GPX3 antioxidative activity in bone
samples [59]. Bdkrb1 plays an important role in inflam-
mation and healing; Bdkrb1 knockout mice displayed
increased bone loss, and bone marrow cells from Bdkrb1
knockout mice exhibited enhanced differentiation into
osteoclasts [60]. The Scarb1 gene product is a high-
density lipoprotein receptor which was shown to influence
bone metabolism; Scarb1 deficiency promoted osteo-
blastogenesis but stunted terminal osteocyte differenti-
ation [61]. When studying NR_024031, also named
DANCR, researchers found that DANCR promoted the
expression of IL-6 and TNF-α, and DANCR-induced IL-6
and TNF-α had bone-resorbing activity indicating that
DANCR is involved in the pathology of osteoporosis and
may be a biomarker for postmenopausal osteoporosis
[63]. DANCR can inhibit the Wnt/β-catenin signal path-
way and suppress the odontogenic differentiation in
human dental pulp cells [64]. Moreover, DANCR can be
activated by Sox4 and promotes cell proliferation and
chondrogenesis in synovium-derived MSCs [65]. These
reports suggest that GPX3, BDKRB1, SCARB1, and
DANCR may play important roles in the osteogenic differ-
entiation of BMSCs.
In the present study, we selected one candidate
lncRNA, XR_111050, to investigate its function on the
osteogenic differentiation of BMSCs. Our experiments
showed that XR_111050 resulted in increased mineralization
in BMSCs. Upregulated osteogenic marker (COL1A2, OCN,
BSP, and OPN) mRNA levels verified that XR_111050
enhanced in vitro osteogenic differentiation in BMSCs.
The activation of multiple transcription factors, such as
RUNX2 and OSX, is associated with MSC osteogenic dif-
ferentiation [66]. Our study found that XR_111050 stimu-
lated the expression of one key transcription factor,
RUNX2, but not the expression of another, OSX, which is
involved in osteogenic differentiation. In addition, our re-
sults also confirmed that XR_111050 could enhance
mineralization in PDLSCs. Taken together, our findings
identified that XR_111050 was an enhancer of the osteo-
genic differentiation regulation of MSCs. XR_111050 is
predicted to be a human hypothetical LOC100509635
miscRNA, a general term for a series of miscellaneous
small RNA, which serves a variety of functions, including
some enzyme-like catalysis and RNA processing [67]. Pre-
vious studies demonstrated that lncRNAs may function by
controlling the transcriptional regulation of neighboring
coding genes in a cis or trans manner [16]. Identifying dif-
ferentially expressed nearby coding mRNA may enhance
our understanding of the function of lncRNAs on the
BMSCs. In this study, we found that XR_111050 is closely
correlated with BDKRB2, MAP3K8, SCARB1, TLR2,
FR000997, FR374455, NR_002744, NR_027293, and
NR_034115 by lncRNA–mRNA CNC network analysis.
We have detected their expression in BMSCs after overex-
pression of XR_111050 to investigate their correlations
and possible mechanism. The results showed that overex-
pression of XR_111050 enhanced the expression of
BDKRB2, MAP3K8, TLR2, and FR000997, and inhibited
the expression of NR_002744 and NR_034115. Our
microarray data showed that the expression of BDKRB2,
MAP3K8, TLR2, and FR000997 was increased, and that of
NR_002744 and NR_034115 was decreased after osteo-
genic differentiation in BMSCs, consistent with the results
of overexpression of XR_111050, indicating that BDKRB2,
MAP3K8, TLR2, and FR000997 might be positive reg-
ulators and NR_002744 and NR_034115 might be
negative regulators for osteogenic differentiation of
BMSCs. In conclusion, these results implied that
XR_111050 may play a role in the osteogenic differ-
entiation regulation of MSCs via a large number of
cooperators or downstream targets, such as DKRB2,
Zhang et al. Stem Cell Research & Therapy  (2017) 8:30 Page 9 of 13
MAP3K8, TLR2, FR000997, NR_002744, and NR_034115.
However, further studies must be performed to investigate
this hypothesis.
Conclusions
We identified the differential expression profiling of cod-
ing and long noncoding transcripts during osteogenic
differentiation of BMSCs with human whole transcrip-
tome microarray. The potential regulatory mechanisms
were identified with bioinformatic analyses. We further
predicted the interactions of differentially expressed cod-
ing and noncoding genes, and identified core regulatory
factors by co-expression networks during osteogenic
differentiation of BMSCs. Our results also suggested that
one lncRNA, XR_111050, is required for osteogenic
differentiation of MSCs. Our studies provide a base for
further understanding the precise role and mechanisms
of these lncRNAs and mRNAs controlling osteogenic
differentiation of MSCs and provide an important
resource for investigation of MSC biology. In addition,
our obtained lncRNAs with differential expression dur-
ing MSC osteogenic differentiation could be potential
targets for bone tissue engineering.
Methods
Cell culture and osteogenic differentiation
BMSCs derived from 18- to 20-year-old males (n = 3)
were obtained from Cyagen Biosciences (Guangzhou,
China). Human impacted third molars were collected
from healthy male patients (16–20 years old). Teeth
were first disinfected with 75% ethanol and then washed
with phosphate-buffered saline. PDLSCs were isolated,
cultured, and identified as previously described [68].
Briefly, PDLSCs were separated from periodontal liga-
ment in the middle one-third of the root. Subsequently,
the periodontal ligament tissue was digested in a solu-
tion of 3 mg/mL collagenase type I (Worthington
Biochemical Corp., Lakewood, NJ, USA) and 4 mg/mL
dispase (Roche Diagnostics Corp., Indianapolis, IN,
USA) for 1 h at 37 °C. Single-cell suspensions were
obtained by cell passage through a 70-μm strainer
(Falcon, BD Labware, Franklin Lakes, NJ, USA). MSC
cultures were grown in a humidified, 5% CO2 incubator
at 37 °C in DMEM alpha modified Eagle’s medium
(Invitrogen, Carlsbad, CA, USA), supplemented with
15% fetal bovine serum (FBS; Invitrogen, Carlsbad, CA,
USA), 2 mmol/L glutamine, 100 U/mL penicillin, and
100 μg/mL streptomycin (Invitrogen, Carlsbad, CA,
USA). The culture medium was changed every 3 days.
All MSCs were used in subsequent experiments after 3–5
passages. For osteogenesis differentiation, MSCs were
seeded at a density of 2.0 × 105 cells/well into six-well
plates with routine medium. When cells reached 80–90%
confluence, the medium was changed, and cells were
grown in osteogenic differentiation medium with the
STEMPRO osteogenesis differentiation Kit (Invitrogen).
The osteogenic differentiation medium was replaced
every 3 days.
Total RNA isolation and microarray hybridization
BMSCs were grown in osteogenic differentiation
medium for 7 days using the StemPro osteogenesis
differentiation kit (Invitrogen); the osteogenic differenti-
ation medium was changed every 3 days. Three total
RNA samples from BMSCs of three different individuals
were extracted separately using TRIzol and the RNeasy
mini kit (Qiagen, Germany). RNA quality and quantity
were confirmed by multiImager and spectrophotometer
(Meriton, China). Each total RNA sample was further
purified using the RNeasy mini kit and RNase-Free
DNase Set (QIAGEN, GmBH, Germany).
Microarray analysis was performed using Human
Transcriptome Array (Affymetrix), covering more than
285,000 coding and noncoding transcripts (>245,000
coding transcripts, >40,000 noncoding transcripts). For
each experimental group, three biological replicates
(three BMSCs RNA samples from three different indi-
viduals) were hybridized. The RNA labeling and micro-
array hybridization were carried out according to the
Affymetrix expression analysis technical manual (by
Genminix Informatics Ltd., Shanghai, China). The arrays
were scanned using the GeneChip® scanner 3000 (Affyme-
trix, CA, USA). The microarray raw data were normalized
with Affymetrix Expression Console software using the
MAS5 statistical algorithm.
Quantitative RT-PCR
qRT-PCR was used to verify the differential expression
of genes that were detected on the microarray and to
detect the expression of osteogenic differentiation
markers. At days 0, 3, 7, 10, and 14 after osteogenic in-
duction, BMSCs were harvested for RNA extraction.
Total RNA was isolated from BMSCs with Trizol re-
agents (Invitrogen). For qRT-PCR, 2 μg aliquots of RNA
as a template were combined with random hexamers
and reverse transcriptase, according to the manufac-
turer’s protocol (Invitrogen). qRT-PCR was performed
using QuantiTect SYBR Green PCR kit (Qiagen,
Germany) and an iCycler iQ Multicolor Real-Time PCR
Detection System. Primer sequences used for qRT-PCR
are listed in Additional file 12 (Table S9). Relative
mRNA levels were calculated using the 2−ΔΔCt method.
The ΔCts were obtained from Ct normalized with
GAPDH. Pearson’s correlation coefficient was further
calculated for each gene using the normalized data to
quantify the consistency between microarray experi-
ments and qRT-PCR (p < 0.05 and R > 0.9).
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Bioinformatic analysis
The bioinformatic analysis was performed (by Genminix
Informatics Ltd., Shanghai, China) as described previ-
ously [68]. Briefly, after normalized data were compared
and filtered, the differentially expressed genes for the
control and experiment group were firstly filtered using
RVM t test (Two Class Dif ) (p < 0.05) for following ana-
lysis. Hierarchical clusters were performed by EPCLUST.
GO analysis was applied to analyze the main function
of the differential expression genes according to the GO
using the two-sided Fisher’s exact test and χ2 test for
classifying the GO category (p < 0.05, FDR < 0.01).
Enrichment of the GO category was calculated for
significance of the function. Go-map analysis was made
to identify the interaction net of the significant GOs of
the differential expression genes.
Pathway analysis was used to discover the significant
pathway of the differential genes according to KEGG,
Biocarta and Reatome, using Fisher’s exact test and χ2 test
(p < 0.05, FDR < 0.01). The enrichment Re of pathways
was calculated. The interaction net of the significant path-
ways of the differential expression genes (Path-Net) was
built to find the interaction among the significant path-
ways directly and systemically according to the interaction
among pathways of the KEGG database.
The gene-gene interaction network (Signal-Net) from
differentially expressed genes was constructed to identify
the molecular networks between the two genes based on
the interaction database from KEGG.
We built a coding-noncoding gene co-expression
network (CNC) to further identify the interactions and
locate core regulatory factors (genes) among genes
according to the normalized signal intensity of specific
expression genes.
Plasmid construction and viral infection
The plasmids were constructed with standard methods;
all structures were verified by appropriate restriction
digestion and/or sequencing. Human full-length XR-
111050 cDNA from BMSCs was produced with a stand-
ard PCR protocol. This sequence was subcloned into the
LV5 lentiviral vector (Genepharma Company, Suzhou,
China). Short-hairpin RNAs (shRNA) with the comple-
mentary sequences of the target genes were subcloned
into the LV3 lentiviral vector (Genepharma Company,
Suzhou, China). For viral infections, MSCs were plated
overnight and then infected with lentiviruses in the
presence of polybrene (6 μg/mL; Sigma-Aldrich, St.
Louis, MO, USA) for 6 h. After 48 h, infected cells
were selected with 1 μg/mL puromycin for 7 days.
The target sequences for the shRNA were: LV3
shRNA (Consh), 5’-TTCTCCGAACGTGTCACGTTT
C-3’; XR-111050 shRNA (XR-111050sh), 5’-GGACG
TGTCTTTCAGGGAAAG-3’.
Alizarin red detection and quantitative calcium analysis
MSCs were grown in osteogenic differentiation
medium using the StemPro osteogenesis differentiation
kit (Invitrogen). For detecting mineralization, cells
were induced for 2 weeks, fixed with 70% ethanol, and
stained with 2% Alizarin red (Sigma-Aldrich, St. Louis,
MO, USA). To quantitatively determine calcium, Alizarin
red was destained with 10% cetylpyridinium chloride in
10 mM sodium phosphate for 30 min at room temperature.
The concentration was determined by measuring the
absorbance at 562 nm on a multiplate reader and compar-
ing to a standard calcium curve with calcium dilutions in
the same solution. The final calcium level in each group
was normalized to the total protein concentration detected
in a duplicate plate.
Statistics
All statistical calculations were performed with SPSS11
statistical software. Statistical analyses included compari-
sons with the t test, Fisher’s exact test, χ 2 test, and the
Pearson correlation, as appropriate; p values less than
0.05 were considered statistically significant.
Additional files
Additional file 1: Table S1. The differentially expressed mRNAs during
osteogenic differentiation of BMSCs. (XLS 139 kb)
Additional file 2: Table S2. The differentially expressed lncRNAs during
osteogenic differentiation of BMSCs. (XLS 185 kb)
Additional file 3: Table S3. The upregulated and downregulated GO
functions during osteogenic differentiation of BMSCs. (XLS 54 kb)
Additional file 4: Table S4. The upregulated and downregulated
pathways during osteogenic differentiation of BMSCs. (XLS 33 kb)
Additional file 5: Table S5. The upregulated and downregulated genes in
significant pathways during osteogenic differentiation of BMSCs. (XLS 111 kb)
Additional file 6: Table S6. The significant pathways enriched by Path-
net during osteogenic differentiation of BMSCs. (XLS 25 kb)
Additional file 7: Table S7. The 92 core genes enriched by Signal-net
during osteogenic differentiation of BMSCs. (XLS 37 kb)
Additional file 8: Figure S1. The co-expression network of mRNAs and
lncRNAs in BMSCs before osteogenic differentiation (CNC). Circles represent
upregulated (red) genes, and downregulated (blue) genes in BMSCs. The
lncRNA genes are encircled in yellow. The lines represent the regulatory
relationships between genes (solid lines represent positive correlations,
dotted lines represent negative correlations). The circle size represents the
degree of centrality. (PNG 3798 kb)
Additional file 9: Figure S2. The co-expression network of mRNAs and
lncRNAs in BMSCs after osteogenic differentiation (CNC). Circles represent
upregulated (red) genes, and downregulated (blue) genes in BMSCs. The
lncRNA genes are encircled in yellow. The lines represent the regulatory
relationships between genes (solid lines represent positive correlations,
dotted lines represent negative correlations). The circle size represents
the degree of centrality. (PNG 4510 kb)
Additional file 10: Table S8. The 13 core regulatory genes by CNC
during osteogenic differentiation of BMSCs. (XLS 27 kb)
Additional file 11: Figure S3. XR_111050 enhanced the osteogenic
differentiation of PDLSCs. The PDLSCs were transduced with XR_111050
lentiviral vector or with empty vector. (A) XR_111050 expression
increased during osteogenic differentiation evaluated by qRT-PCR. (B) The
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enhanced XR_111050 expression in PDLSCs was verified with qRT-PCR.
(C,D) The enhanced XR_111050 expression enhanced mineralization of
PDLSCs shown by Alizarin red staining (C) and calcium quantitative
analysis (D). Error bars represent SD (n = 3). **p < 0.01. (TIFF 1312 kb)
Additional file 12: Table S9. The primer sequences used for qRT-PCR.
(XLS 30 kb)
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